Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Krzysztof Pstrągowski"'
Autor:
Tomasz Topoliński, Krzysztof Pstrągowski, Aldona Kubica, Robert Gajda, Łukasz Pietrzykowski, Ewa Zabielska, Tamara Sukiennik, Małgorzata Jasiewicz, Marzena Wawrzyniak, Malwina Barańska, Julia Maria Umińska, Lidia Manelska, Ewa Obońska, Michał Siedlaczek, Piotr Michalski, Ewa Laskowska, Klaudyna Grzelakowska, Jacek Kryś, Piotr Adamski, Piotr Niezgoda, Małgorzata Ostrowska, Eliano Pio Navarese
Publikováno v:
Medical Research Journal.
Autor:
Małgorzata Jasiewicz, Jacek Kryś, Klaudyna Grzelakowska, Jacek Kubica, Krzysztof Pstrągowski, Michał Siedlaczek, Jakub Ratajczak
Publikováno v:
Medical Research Journal. 6:114-118
Introduction: Heart failure (HF) places a significant economic burden on the health care system all over the world mainly due to frequent and repetitive hospitalizations. Thus, there is a need for both cost-effective and efficient therapeutic options
Autor:
Tomasz Fabiszak, Piotr Łach, Michał Kasprzak, Krzysztof Pstrągowski, Eliano Pio Navarese, Julia M. Umińska, Jacek Kubica, Jakub Ratajczak
Publikováno v:
Cardiol J
Background: Mild therapeutic hypothermia (MTH) is a recommended treatment of comatose patients after out-of-hospital cardiac arrest (OHCA). The aim of the study was to examine determinants of clinical outcome in OHCA survivors treated with MTH and va
Autor:
Julia M. Umińska, Jakub Ratajczak, Krzysztof Pstrągowski, Katarzyna Buszko, Klaudiusz Nadolny, Tomasz Fabiszak, Klemen Steblovnik, Marko Noč, Jacek Kubica
Publikováno v:
Cardiology Journal.
The aim of the study was to assess the antiplatelet effect of ticagrelor in patients with myocardial infarction (MI) after out-of-hospital cardiac arrest (OHCA) treated with percutaneous coronary intervention (PCI) and mild therapeutic hypothermia (M
Autor:
Jolanta M. Siller-Matula, Bernd Jilma, Jacek Kubica, Karolina Obońska, Małgorzata Jasiewicz, Michał Siedlaczek, Diana A. Gorog, Michał Kasprzak, Krzysztof Pstrągowski, Ryszard Dobosiewicz
Publikováno v:
Cardiology Journal.
Background : Elevations of hepatic transaminase (serum alanine transaminase [ALT] and serum aspartate aminotransferase [AST]) levels in patients with acute coronary syndrome (ACS), although transient, may result in exclusions from clinical efficacy t
Autor:
Marcin Gruchała, Mariusz Gąsior, Andrzej Budaj, Aldona Kubica, Eliano Pio Navarese, Krzysztof Pstrągowski, Piotr Niezgoda, Andrzej Kleinrok, Klaudiusz Nadolny, Jacek Legutko, Young-Hoon Jeong, Tomasz Fabiszak, Maciej Lesiak, Jarosław D. Kasprzak, Robert J. Gil, Bernd Jilma, Agnieszka Tycińska, Salvatore Di Somma, Dimitrios Alexopoulos, Stefan Grajek, Jolanta M. Siller-Matula, Katarzyna Buszko, Giuseppe Specchia, Jacek Kubica, Stefan James, Udaya S. Tantry, Piotr Adamski, Miłosz Jaguszewski, Wojciech Wojakowski, Jolita Badarienė, Wiktor Kuliczkowski, Janina Stępińska, Paul A. Gurbel, Dariusz Dudek, Diana A. Gorog, Monica Verdoia
Publikováno v:
Cardiology journal, Gdansk : Via Medica, 2020, vol. 27, no. 6, p. 661-676
Cardiol J
Cardiol J
The increased risk of non-cardiovascular death in patients receiving clopidogrel or prasugrel in comparison with the placebo group in the dual antiplatelet therapy (DAPT) trial in contrast to the decreased risk of cardiovascular death and all-cause d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a8ae2dfd6ee4f8fb30c7551a366c38b
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-435435
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-435435
Autor:
Wiktor Dariusz Sroka, Malwina Barańska, Krzysztof Pstrągowski, Piotr Niezgoda, Jolanta M. Siller-Matula, Jilma Bernd, Natalia Skibińska, Jacek Kubica, Eliano Pio Navarese, Joanna Sikora, Katarzyna Buszko, Diana A. Gorog, Michał Piotr Marszałł
Publikováno v:
Thrombosis and Haemostasis. 118:2126-2133
Extensive search for methods of overcoming morphine-related delay of the absorption and onset of action of oral P2Y12 inhibitors in patients presenting with acute coronary syndrome is on-going. The aim of the trial was to investigate whether metoclop
Autor:
Jacek Kubica, Joanna Sikora, Grzegorz Grześk, Tomasz Fabiszak, Michał Piotr Marszałł, Adam Sikora, Przemysław Sobczak, Natalia Skibińska, Krzysztof Pstrągowski
Publikováno v:
Thrombosis Research. 159:76-81
Levosimendan has been developed for treatment of severe heart failure. The favorable hemodynamic effect of levosimendan is related to its unique dual mechanism of action - increase of the contractile force of the myocardium caused by enhanced sensiti
Autor:
Tomasz Fabiszak, Grzegorz Grześk, Krzysztof Pstrągowski, Joanna Sikora, Julia M. Umińska, Michał Piotr Marszałł, Przemysław Paciorek, Jacek Kubica, Marek Koziński
Publikováno v:
Medical Research Journal. 1:115-119
In summary, the available data on the antiplatelet efficacy of P2Y12 receptor inhibitors suggest their less potent and/or delayed effect in patients undergoing mild therapeutic hypothermia (MTH). However, previous studies do not explain the mechanism
Autor:
Piotr Niezgoda, Michał Piotr Marszałł, Grzegorz Grześk, Jacek Kubica, Malwina Barańska, Joanna Sikora, Emilia Siemińska, Krzysztof Pstrągowski, Aleksandra Karczmarska-Wódzka
Publikováno v:
Medical Research Journal. 1:68-71
Introduction. Nowadays, due to the “morphine effect”, the screening of methods that provide quick and effective platelet inhibition with oral P2Y12 inhibitors administrated simultaneously with morphine in patients with acute coronary syndromes ar